期刊
INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 268, 期 -, 页码 80-84出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2018.05.061
关键词
Major bleeding; Non-vitamin K antagonist oral anticoagulants; Vitamin-K antagonists; Warfarin
has changed the therapeutic landscape in the prevention of thromboembolic events. Although NOACs compared to vitamin K antagonists (VKAs) have demonstrated a similar or slightly lower rate of major bleeding and a lower rate of intracranial or fatal bleeding, hemorrhaging still represents the main adverse effect of anticoagulant treatment. This review reports data on the rates of major bleeding with old and new oral anticoagulants. It analyses laboratory tests that can be used to assess the intensity of anticoagulation in patients treated with oral anticoagulants and discusses general measures to implement in managing major bleeding. (C) 2018 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据